Twitter Beğeni Hilesi

Editorial: Treating Iron Deficiency in Heart Failure nej.md/3subhjb #ESCCongress #cardiology

An overview of a standardized diagnostic approach to acute #myocarditis in a broad population. #AHAJournals Pieter Martens W. H. Wilson Tang, MD ahajrnls.org/3YY4v1l

Attending #HFSA2023 in Cleveland? Don’t miss Cleveland Clinic’s satellite symposium on Sat, 10/7! Register (free!): ccfcme.org/CCFHeartFailur… Randall Starling Maria Mountis Edward Soltesz MD MPH Amit Goyal MD MAS Eileen Hsich Pavan Bhat Samir Kapadia Michael Tong W. H. Wilson Tang, MD Trejeeve (Tre) Martyn

🌟 Calling all #heartfailure experts! 📢 Your chance to shine at #THT2024 is here! 🔬 Submit your science for the opportunity to present and become faculty! 🗣️ tht2024.crfconnect.com/topics-categor… Dan Burkhoff MD PhD David J. Cohen, MD, MSc George Dangas, MD, MACC, MSCAI Juan F. Granada Dr Roxana Mehran Sahil A. Parikh, MD Tricia Rawh

Proud of my research team presenting our work at #hfsa2023 @hfsa Cleveland Clinic Heart, Vascular & Thoracic Cleveland Clinic Lerner Research Institute

Two decades have gone by fast! Congrats Randall Starling on receiving the #hfsa2023 Lifetime Achievement Award. Josef Stehlik Cleveland Clinic Heart, Vascular & Thoracic @hfsa

Emerging insights into the pathophysiologic basis, mode action and proof of concept features of renal assist devices in acute decompensated heart failure: bit.ly/3Q1AQjw #JACCHF #HeartFailure Pieter Martens W. H. Wilson Tang, MD

This phase 3 trial of patisiran, a small interfering RNA that targets hepatic production of the transthyretin protein, showed efficacy in treating transthyretin-mediated (ATTR) cardiac amyloidosis. Read the full APOLLO-B trial results: nej.md/4081o7o

Prognostic Value of Natriuretic Peptide Levels for Adverse Renal Outcomes in Patients With Moderate to Severe Acute Kidney Injury With or Without Heart Failure. #AHAJournals W. H. Wilson Tang, MD ahajrnls.org/40J9bcl

News in EHJ: Promises and challenges of targeting anti-CXCR3 autoantibodies in cardiovascular disease! academic.oup.com/eurheartj/adva… #cardioprotective #therapy #autoantibodies #G-protein #receptors #cardiotwitter European Society of Cardiology @ESC_journals

#CVCT2023 #JACCHF SimPub: Meta-analysis of all randomized controlled trials in #HeartFailure. IV iron reduces both CV-death and HF-readmissions. But it might be time to redefine our definition of iron deficiency based on TSAT. bit.ly/3N5qfU4 CVCT - CardioVascular Clinical Trialists Pieter Martens

🚨 Act Fast! 🕒 Deadlines for #THT2024 Call for Science are right around the corner! 👉 Submit abstracts, fellows abstracts, fellows challenging cases, and THT Shark Tank Innovation Competition by Dec. 4, 2PM ET. 👉 Submit late-breaking clinical science/first-in-human and early

Q: Is intravenous iron beneficial for patients with #heartfailure and iron deficiency? A: In patients with HF and iron deficiency, treatment with IV iron can reduce CV deaths and HF hospitalizations. bit.ly/4aL4MKs #JACCHF

The MF is thrilled to announce one of the 2023 Fellowship Grant recipients, Dr. Simon Vanhentenrijk, MD, Pharm D, of the Cleveland Clinic! Read about his work below. myocarditisfoundation.org/the-myocarditi…

So incredibly proud of Cleveland Clinic representation at #CMR2024 in London Society for Cardiovascular Magnetic Resonance. 14 oral presentations and a ECA finalist. Celebrating at last night’s dinner! Animesh (Aashoo) Tandon, MD, MS DebbieKwonMD Cardiovascular Innovation Research Center CCF HVTI Cleveland Clinic Heart, Vascular & Thoracic Cleveland Clinic Lerner College of Medicine

The new #JACCHF issue is now out! Hemodynamic gain index and peak rate pressure product can identify patients w/ #HFrEF at risk of poor clinical outcomes. This allows prognostication of #HeartFailure even when CPET is not available. bit.ly/49p3hjk #CHF W. H. Wilson Tang, MD

Niacin, the B vitamin that was previously used to improve lipid profile and reduce the risk of heart disease, promotes arterial inflammation and cardiovascular risk through its metabolites nature.com/articles/s4159… Nature Medicine

Great start with our fearless leader Dan Burkhoff MD PhD kicking off exciting #THT2024 with 3 days of packed agenda and exciting discussions in #heartfailure innovations.

Acetazolamide prevents loop diuretic resistance. #THT2024 Wilfried Mullens W. H. Wilson Tang, MD

#Perspective: Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases Cleveland Clinic Lerner Research Institute W. H. Wilson Tang, MD ahajournals.org/doi/10.1161/CI…